Team:Uppsala-Swedenbrickbat

From 2010.igem.org

(Difference between revisions)
Line 535: Line 535:
<P><BR><BR>
<P><BR><BR>
</P>
</P>
 +
<script type="text/javascript"><!--
 +
google_ad_client="pub-9324829980761295";
 +
google_ad_host="pub-1556223355139109";
 +
google_ad_width=728;
 +
google_ad_height=15;
 +
google_ad_format="728x15_0ads_al_s";
 +
google_ad_host_channel="0001";
 +
google_color_border="FFFFFF";
 +
google_color_bg="FFFFFF";
 +
google_color_link="CC6600";
 +
google_color_url="333333";
 +
google_color_text="333333";
 +
//--></script>
 +
<script type="text/javascript"
 +
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
 +
</script>
</body>
</body>

Revision as of 15:43, 2 April 2010

Brick Biosafety Assesment Tool

Rate your Component on a scale of 1 to 5 (1 being the safest) for below questions

  1. How would you classify the trait being expressed in the Part?

    1
    2
    3
    4
    5

  2. How would you classify the donor organisms of the genes used?

    1
    2
    3
    4
    5

  3. If the part or device contains sub-parts, how would you classify the components?

    1
    2
    3
    4
    5

  4. How would you classify the efficiency of promoters in the part or device?

    1
    2
    3
    4
    5

  5. How would you classify the Transcriptome, Proteome and Metabolome by considering factors such as unintended splicing sites and reading frame change?

    1
    2
    3
    4
    5

  6. How would you classify the gene products based on Antigenicity and pathogenesis?

    1
    2
    3
    4
    5

  7. How would you classify the effectiveness of the part or device to survive outside lab conditions?

    1
    2
    3
    4
    5




Retrieved from "http://2010.igem.org/Team:Uppsala-Swedenbrickbat"